Not in meta‐analysis |
Study |
Outcome |
Notes |
Insufficient data |
Lipman 1966 |
Target symptoms (doctor‐ and other observer‐reported outcomes) |
Not enough data for meta‐analysis. Reports means and number of participants only. Standard deviation unclear. Qualitatively, no strong direction of benefit (active placebo: mean = 2.15, N = 99, standard placebo: mean = 2.17, N = 90). |
Shader 1964 |
Revised Clyde Mood Scales (observer) |
Not enough data for meta‐analysis. However, unclear if the relevant outcome reported in the trial has a clear directionality. |
No relevant data |
Berna 2017 |
No indication of a relevant outcome measured |
|
Bjørkedal 2011 |
No indication of a relevant outcome measured |
Measured laser‐evoked potentials with EEG recordings, including N2 and P2 amplitudes and latencies, to rule out the possible effects of response bias. We were uncertain whether they could be interpreted as clinically relevant observer‐reported outcomes of benefit and therefore did not use them for analysis. |
Dellemijn 1997 |
No indication of a relevant outcome measured |
|
Fangman 1963 |
No indication of a relevant outcome measured |
|
Malmstrom 2006 |
No indication of a relevant outcome measured |
|
Prosenz 2017 |
No indication of a relevant outcome measured |
Measured sedation using bispectral index (BIS) and Richmond Agitation‐Sedation Scale (RASS) as well as psychomotor and executive functions using the Groton Maze Learning Test Task and the Detection Task. We decided that they were not clinically relevant observer‐reported outcomes of benefit and therefore did not use them for analysis. |
Rief 2012 |
No indication of a relevant outcome measured |
|
Woodrow 1988 |
No indication of a relevant outcome measured |
|